Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Biotium Dual Apoptosis Assay with NucView 488 Caspase-3 Substrate and CF594 Annexin V (50 assays)

Supplier:  Biotium 30067

Encompass_Preferred

This kit includes two apoptosis markers, NucView 488 Caspase-3 Substrate (green) and CF594 conjugated Annexin (red), for profiling apoptotic cells with respect to two important apoptosis events, caspase-3 activation and phosphatidylserine (PS) translocation, by flow cytometry or fluorescence microscopy.Unlike traditional fluorogenic caspase substrates that inhibit caspase activity or require cell lysis, NucView 488 a novel fluorogenic caspase-3 substrate, is non-inhibitory to caspases, and permits apoptosis detection within individual intact cells, in real-time. The non-fluorescent substrate is cleaved by caspase-3/7 in apoptotic cells releasing a high-affinity DNA dye that migrates to the nucleus and emits bright green fluorescence, allowing caspase-3/7 detection and visualization of apoptotic nuclear morphology. Exposed PS on apoptotic cells is detected by Annexin V conjugated to CF594 (Abs/Em: 593/614 nm), a bright and photostable deep red dye spectrally similar to Texas Red.

Catalog No. NC1231194


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.